Pharmaceutical

Dyno and Roche collaborate on neurological gene therapies

Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological diseases.

Oct 26, 2024 - 04:00
Dyno and Roche collaborate on neurological gene therapies
Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological diseases.
Read the original article

Tags:

Previous Article

Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments

Next Article

Takeda and BMC partner to decarbonise US healthcare sector

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FDA clears first over-the-counter continuous glucose monitor

STAT+: FDA clears first over-the-counter continuous glu...

Mar 6, 2024

Senate bill would permanently extend Covid-era rules on telehealth addiction treatment

Senate bill would permanently extend Covid-era rules on...

Nov 3, 2023

STAT+: Hearing on Medicare drug price negotiation gets unusually heated

STAT+: Hearing on Medicare drug price negotiation gets ...

Sep 20, 2023